136 related articles for article (PubMed ID: 33363862)
21. Angiotropic lymphoma: an immunophenotypically and clinically heterogeneous lymphoma.
Yegappan S; Coupland R; Arber DA; Wang N; Miocinovic R; Tubbs RR; Hsi ED
Mod Pathol; 2001 Nov; 14(11):1147-56. PubMed ID: 11706077
[TBL] [Abstract][Full Text] [Related]
22. CD 5+ Peripheral B Cell Lymphoma With Transformation to CD 5+ Diffuse Large B Cell Lymphoma in the CNS: A Case Report Treated With Rituximab, High Dose Methotrexate, Cytarabine, and Intrathecal Methotrexate.
Uczkowski D; Apor E
Cureus; 2022 Jul; 14(7):e27201. PubMed ID: 35898806
[TBL] [Abstract][Full Text] [Related]
23. Cooccurrence of CD10-Positive and CD10-Negative Mantle Cell Lymphoma Complicated With Central Nervous System Involvement Solely by CD10-Positive Population.
Fukushima N; Mino T; Arihiro K; Ichinohe T
Cureus; 2022 Jan; 14(1):e21341. PubMed ID: 35186599
[TBL] [Abstract][Full Text] [Related]
24. CD5-positive follicular lymphoma: a case report and literature review.
Sekiguchi Y; Imai H; Wakabayashi M; Sawada T; Ichikawa K; Komatsu N; Noguchi M
Intern Med; 2011; 50(8):899-904. PubMed ID: 21498939
[TBL] [Abstract][Full Text] [Related]
25. CD5-negative mantle cell lymphoma resembling extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue : a case report.
Hashimoto Y; Omura H; Tanaka T; Hino N; Nakamoto S
J Clin Exp Hematop; 2012; 52(3):185-91. PubMed ID: 23269078
[TBL] [Abstract][Full Text] [Related]
26. CD5-positive diffuse large B cell lymphoma arising from a CD5-positive follicular lymphoma.
Vassallo J; Bousquet M; Quelen C; Al Saati T; Delsol G; Brousset P
J Clin Pathol; 2007 May; 60(5):573-5. PubMed ID: 17513519
[TBL] [Abstract][Full Text] [Related]
27. t(6;14)(q15;q32) in a patient with CD5+CD10+ diffuse large B-cell lymphoma.
Hayama M; Niitsu N; Higashihara M; Nakamine H; Miura I
Int J Hematol; 2007 Aug; 86(2):147-9. PubMed ID: 17875529
[TBL] [Abstract][Full Text] [Related]
28. Expression of programmed cell death ligand-1 by immune cells in the microenvironment is a favorable prognostic factor for primary diffuse large B-cell lymphoma of the central nervous system.
Tsuyuki Y; Ishikawa E; Kohno K; Shimada K; Ohka F; Suzuki Y; Mabuchi S; Satou A; Takahara T; Kato S; Miyagi S; Ozawa H; Kawano T; Takagi Y; Hiraga J; Wakabayashi T; Nakamura S
Neuropathology; 2021 Apr; 41(2):99-108. PubMed ID: 33269495
[TBL] [Abstract][Full Text] [Related]
29. Establishment of CD5 and CD10 double-positive mature B-cell line, WILL1, showing complex 8q24 translocation involving 14q32 and 6q27.
Uneda S; Gotoh M; Sonoki T; Nishida K; Nakamura Y; Kurimoto M; Hanaoka N; Matsuoka H; Taniwaki M; Nakakuma H
Int J Hematol; 2008 Dec; 88(5):536-542. PubMed ID: 18972186
[TBL] [Abstract][Full Text] [Related]
30. Pure intravascular recurrence of CD5-positive diffuse large B-cell lymphoma primarily arising from the nasal cavities.
Kano R; Masaie H; Hino A; Yasuoka H; Nagata S; Ishikawa J; Nakatsuka SI
Diagn Pathol; 2018 Jul; 13(1):46. PubMed ID: 30041681
[TBL] [Abstract][Full Text] [Related]
31. Most primary central nervous system diffuse large B-cell lymphomas occurring in immunocompetent individuals belong to the nongerminal center subtype: a retrospective analysis of 31 cases.
Hattab EM; Martin SE; Al-Khatib SM; Kupsky WJ; Vance GH; Stohler RA; Czader M; Al-Abbadi MA
Mod Pathol; 2010 Feb; 23(2):235-43. PubMed ID: 19935644
[TBL] [Abstract][Full Text] [Related]
32. B-cell lymphomas with coexpression of CD5 and CD10.
Dong HY; Gorczyca W; Liu Z; Tsang P; Wu CD; Cohen P; Weisberger J
Am J Clin Pathol; 2003 Feb; 119(2):218-30. PubMed ID: 12579992
[TBL] [Abstract][Full Text] [Related]
33. Flow cytometry aneuploidy and cell cycle indexing as a possible tool for differentiating between CD10
Azoulay D; Cohen HI; Dementiev E; Eshel E; Akria L; Shaoul E; Horowitz N
Cytometry B Clin Cytom; 2020 Sep; 98(5):449-453. PubMed ID: 31816181
[TBL] [Abstract][Full Text] [Related]
34. CD5-Positive Primary Cutaneous Diffuse Large B-Cell Lymphoma-Leg Type.
Papoudou-Bai A; Marinos L; Vassou A; Kapsali E; Kanavaros P
Case Rep Dermatol Med; 2019; 2019():3730915. PubMed ID: 30792929
[TBL] [Abstract][Full Text] [Related]
35. Immune evasion-related extranodal large B-cell lymphoma: A report of six patients with neoplastic PD-L1-positive extranodal diffuse large B-cell lymphoma.
Suzuki Y; Sakakibara A; Shimada K; Shimada S; Ishikawa E; Nakamura S; Kato S; Takahara T; Asano N; Satou A; Kohno K
Pathol Int; 2019 Jan; 69(1):13-20. PubMed ID: 30601579
[TBL] [Abstract][Full Text] [Related]
36. Intravascular B-cell lymphoma with leukemic presentation: case report and literature review.
Xanthopoulos V; Galanopoulos AG; Paterakis G; Apessou D; Argyrakos T; Goumakou E; Papadhimitriou SI; Savvidou I; Georgiakaki M; Anagnostopoulos NI
Eur J Haematol; 2008 Feb; 80(2):177-81. PubMed ID: 18076638
[TBL] [Abstract][Full Text] [Related]
37. [Primary adrenal diffuse large B-cell lymphoma positive for CD5 and CD10].
Yamamoto Y; Sumii Y; Shiraishi Y; Ikeuchi K; Yamada H; Niiya D; Shiote Y; Yamamoto K; Imajo K
Rinsho Ketsueki; 2017; 58(2):161-164. PubMed ID: 28321095
[TBL] [Abstract][Full Text] [Related]
38. Intraocular lymphoma: diagnostic approach and immunophenotypic findings in vitrectomy specimens.
Raparia K; Chang CC; Chévez-Barrios P
Arch Pathol Lab Med; 2009 Aug; 133(8):1233-7. PubMed ID: 19653716
[TBL] [Abstract][Full Text] [Related]
39. CD10 expression in peripheral T-cell lymphomas complicated by a proliferation of large B-cells.
Reichard KK; Schwartz EJ; Higgins JP; Narasimhan B; Warnke RA; Natkunam Y
Mod Pathol; 2006 Mar; 19(3):337-43. PubMed ID: 16400325
[TBL] [Abstract][Full Text] [Related]
40. Phenotypical Characterization and Clinical Outcome of Canine Burkitt-Like Lymphoma.
Aresu L; Agnoli C; Nicoletti A; Fanelli A; Martini V; Bertoni F; Marconato L
Front Vet Sci; 2021; 8():647009. PubMed ID: 33816589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
